A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab
Clinical trial NCT04493424 · TERMINATED
Trial details
- NCT number
- NCT04493424
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-04
- Primary completion
- 2023-01-16
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.